findmyKOL
Clinical trialNCT01894256CompletedPhase 1Interventional

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function

SponsorAstraZenecaEnrollment56Solid Tumours
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a 2-part study in patients with advanced solid tumours. Part A will investigate the PK of olaparib in patients with mild or moderate renal impairment compared to patients with normal renal function; Part B will allow eligible study patients continued access to olaparib after the PK phase and will provide additional safety data.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Research Site

    Brussels (Jette), Belgium

  • Research Site

    Edegem, Belgium

  • Research Site

    Leuven, Belgium

  • Research Site

    Liège, Belgium

  • Research Site

    Wilrijk, Belgium

Denmark
  • Research Site

    Herlev, Denmark

  • Research Site

    København Ø, Denmark

France
  • Research Site

    Bordeaux, France

  • Research Site

    Dijon, France

Netherlands
  • Research Site

    Amsterdam, Netherlands

  • Research Site

    Maastricht, Netherlands

United Kingdom
  • Research Site

    Newcastle upon Tyne, United Kingdom

  • Research Site

    Surrey, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Olaparib tablet dosing
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2013
Primary completion
31 Mar 2015
Completion
29 Feb 2016
Last update posted
13 Oct 2016
Registered enrollment
56
Registry id
NCT01894256

Cross-registrations

EU-CTR / CTIS (EudraCT)2013-002225-30
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.